FDA approves Phase II of stem cell trial for ALS led by U-M’s Dr. Eva Feldman
ANN ARBOR, Mich. — For nearly two years, University of Michigan neurologist Eva Feldman, M.D., Ph.D. has led the nation’s first clinical trial of stem cell injections… Read more »
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
ROCKVILLE, Md., Jan. 21 /PRNewswire-FirstCall/ — Neuralstem, Inc. (NYSE Amex: CUR) announced that the first ALS patient was treated with its spinal cord stem cells yesterday at… Read more »
Stem cell trial for ALS treatment gets FDA OK
From ChicagoTribune.com A University of Michigan neurologist is the principal investigator for the first human clinical trial of a stem cell treatment for amyotrophic lateral sclerosis. Dr…. Read more »
Researchers plan trial for Lou Gehrig’s disease therapy
By Brooke Adams, The Salt Lake Tribune The mice at the top of a column of stacked plastic bins at Q Therapeutics are shivering so hard they… Read more »